1. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. & Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912–915 (1990).
2. Baker, S. J. et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50, 7717–7722 (1990).
3. Olivier, M. et al. The IARC TP53 database: new online mutations analysis and recommendations to users. Hum. Mutat. 19, 607–614 (2002).
4. Olivier, M., Hussain, S. P., Caron de Fromentel, C., Hainaut, P. & Harris, C. C. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci. Public. 247-270 (2004).
5. Olivier, M., Hollstein, M. & Hainaut, P. TP53 mutations in human cancers: origins, consequences and clinical use. Cold Spring Harb. Perspect. Biol. 2, a001008 (2010).